ID   DHSF-BR16
AC   CVCL_C0V0
SY   Department of Health Science of Florence-Breast 16
DR   Wikidata; Q112929457
RX   PubMed=33863935;
CC   Characteristics: ER-negative, PR-negative and ERBB2-positive (PubMed=33863935).
CC   Doubling time: 28 hours (PubMed=33863935).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
RX   PubMed=33863935; DOI=10.1038/s41598-021-87362-0; PMCID=PMC8052418;
RA   Nobili S., Mannini A., Parenti A., Raggi C., Lapucci A., Chiorino G.,
RA   Paccosi S., Di Gennaro P., Vezzosi V., Romagnoli P., Susini T.,
RA   Coronnello M.;
RT   "Establishment and characterization of a new spontaneously
RT   immortalized ER(-)/PR(-)/HER2(+) human breast cancer cell line,
RT   DHSF-BR16.";
RL   Sci. Rep. 11:8340.1-8340.15(2021).
//